Liansong Yiboting Tablets

**Liansong Yiboting Tablets** are an oral multi-herb traditional Chinese medicine investigational product developed by Jiangxi Baishen Pharmaceutical for coronary heart disease with ventricular premature beats in patients with the traditional Chinese medicine pattern of qi and yin deficiency with blood stasis and heat. A randomized, double-blind, placebo-controlled, single-center Phase IIa Chinese trial, CTR20201327, evaluated its efficacy and safety in this population. Publicly available quality-control research identifies prepared licorice root and rhizome, Danshen root and rhizome, lotus plumule, Corydalis rhizome, and Sophora flavescens root among the herbal materials analyzed. Its specific molecular targets and pharmacologic antiarrhythmic mechanism have not been publicly established. ([pharnexcloud.com](https://www.pharnexcloud.com/data/lcsy_313878faf9e0443f0a59870526e3c75c.html))

Other names

莲松异搏停片